Banerjee D, Zhao S C, Tong Y, Steinherz J, Gritsman K, Bertino J R
Molecular Pharmacology and Therapeutics Program, Sloan Kettering Institute for Cancer Research, New York, NY 10021, USA.
Cancer Gene Ther. 1994 Sep;1(3):181-4.
Chinese hamster ovary (CHO) DHFR-cells were converted to the DHFR+ (dihydrofolate reductase) phenotype when transfected with a mammalian expression vector containing the murine mutant Trp15 DHFR cDNA. Transfection of the Trp15 DHFR cDNA into wild-type CHO cells resulted in resistance to high levels of methotrexate (MTX) in vitro indicating that this mutant DHFR cDNA can act as a dominant marker. Southern and Northern blot analyses of transfected cells indicated that the transfected mutant DHFR cDNA was integrated and expressed. Gene copy number analysis showed that the Trp15 cDNA was amplifiable in increasing concentrations of MTX. Transfection of murine bone marrow progenitor cells with the Trp15 mutant DHFR cDNA resulted in MTX resistant colony forming units-granulocyte macrophage.
当用含有鼠突变型Trp15二氢叶酸还原酶(DHFR)cDNA的哺乳动物表达载体转染时,中国仓鼠卵巢(CHO)DHFR-细胞转变为DHFR+(二氢叶酸还原酶)表型。将Trp15 DHFR cDNA转染到野生型CHO细胞中,使其在体外对高水平的甲氨蝶呤(MTX)产生抗性,这表明该突变型DHFR cDNA可作为显性标记。对转染细胞进行Southern和Northern印迹分析表明,转染的突变型DHFR cDNA已整合并表达。基因拷贝数分析显示,Trp15 cDNA在MTX浓度增加时可被扩增。用Trp15突变型DHFR cDNA转染鼠骨髓祖细胞,产生了对MTX有抗性的集落形成单位 - 粒细胞巨噬细胞。